本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (4747)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 27, 2024 (publication date) through May 10, 2026
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Hepatology
ISSN
1948-5182
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Bouare N, Delwaide J. Interleukin-mediated therapies in liver diseases and comorbidity effects. World J Hepatol 2024; 16(7): 980-989 [PMID: 39086534 DOI: 10.4254/wjh.v16.i7.980] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Bouare N, Delwaide J. Interleukin-mediated therapies in liver diseases and comorbidity effects. World J Hepatol 2024; 16(7): 980-989 [PMID: 39086534 DOI: 10.4254/wjh.v16.i7.980] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v16/i7/980.htm |
| 编号 | Citing Articles |
| 1 |
Chunmei Ran, Xiaoyan Gao, Yongqin Zhou, Chibing Dai. Critical role of interleukin-33 in pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1762478
|